Crispr Therapeutics Viking Therapeutics: 2026 Stock Showdown
As biotech investors look to 2026, crispr therapeutics viking therapeutics presents two distinct paths: gene editing ...
Evaluate whether travel rewards or cash back cards are better for you. Find the card that maximizes your benefits.
26,293 articlesAs biotech investors look to 2026, crispr therapeutics viking therapeutics presents two distinct paths: gene editing ...
Tempus AI is set to report quarterly earnings after the close, with investors watching for growth signals and profita...
Harmony Gold Mining Stock slid about 12% over the week as gold prices cooled and rate expectations shifted. This arti...
As UnitedHealth readies its 2026 earnings, investors want clarity on growth, margins, and risk. This guide breaks dow...
Oil has crossed the $100 mark, creating income opportunities in energy. Here are two no-brainer energy dividend stock...
Zevra Therapeutics stock zoomed after a strong earnings release, delivering revenue growth and a first GAAP profit. T...
Roblox faces a tough year in the market, but a rebound isn’t off the table. This guide breaks down the business, risk...
When Medicare Part B premiums topped the $200 mark, many retirees felt the impact in real time. This guide explains w...
Garmin stock soared this week after the GPS giant posted a solid Q4 and guided higher for 2026. This article breaks d...
The chatter around ad tech is hard to ignore, and Trade Desk sits at the center. This deep dive explains what fuels t...
A single photograph can reveal more than success; it exposes the juggling act between ambition and money. This articl...
When archer aviation stock plummeted, traders searched for the root causes. This guide breaks down the catalysts, inc...